Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 95.48 USD 0.81% Market Closed
Market Cap: 141.5B USD
Section:
 

Relative Value

The Relative Value of one BSX stock under the Base Case scenario is 96.87 USD. Compared to the current market price of 95.48 USD, Boston Scientific Corp is Undervalued by 1%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BSX Relative Value
Base Case
96.87 USD
Undervaluation 1%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.3
P/S
P/S
Price to Sales
7.3
vs History
28
vs Industry
14
Median 3Y
7.3
Median 5Y
5.8
Industry
2.3
Forward
7
More Details
50.7
P/E
P/E
Price to Earnings
50.7
vs History
88
vs Industry
5
Median 3Y
68.7
Median 5Y
69.1
Industry
22.5
Forward
31.1
More Details
30.6
P/OCF
P/OCF
Price to OCF
30.6
vs History
85
vs Industry
5
Median 3Y
40
Median 5Y
37.4
Industry
14.4
More Details
37.9
P/FCFE
P/FCFE
Price to FCFE
37.9
vs History
71
vs Industry
12
Median 3Y
43.1
Median 5Y
48.3
Industry
21.4
More Details
6
P/B
P/B
Price to Book Value
6
vs History
20
vs Industry
9
Median 3Y
5.5
Median 5Y
4.2
Industry
2.2
More Details
7.8
EV/S
EV/S
Enterprise Value to Sales
7.8
vs History
30
vs Industry
12
Median 3Y
7.8
Median 5Y
6.4
Industry
2.5
Forward
7.5
More Details
11.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.4
vs History
26
vs Industry
14
Median 3Y
11.3
Median 5Y
9.4
Industry
5.2
More Details
29.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
29.7
vs History
42
vs Industry
7
Median 3Y
29.6
Median 5Y
28.8
Industry
11.9
Forward
24.5
More Details
40.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
40.3
vs History
55
vs Industry
7
Median 3Y
42.4
Median 5Y
42.3
Industry
16.8
Forward
27.1
More Details
32.7
EV/OCF
EV/OCF
Enterprise Value to OCF
32.7
vs History
90
vs Industry
5
Median 3Y
42.6
Median 5Y
41.1
Industry
14.5
More Details
39.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
39.6
vs History
95
vs Industry
6
Median 3Y
57.8
Median 5Y
57.4
Industry
18.6
More Details
3.7
EV/IC
EV/IC
Enterprise Value to IC
3.7
vs History
25
vs Industry
17
Median 3Y
3.5
Median 5Y
2.6
Industry
1.9
More Details

Multiples Across Competitors

BSX Competitors Multiples
Boston Scientific Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Boston Scientific Corp
NYSE:BSX
141.5B USD 7.3 50.7 29.7 40.3
US
Abbott Laboratories
NYSE:ABT
219.9B USD 5 15.7 20.1 27.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
203B USD 21.1 73.9 56.7 69.1
US
Stryker Corp
NYSE:SYK
133.3B USD 5.5 45.3 22.1 26.8
IE
Medtronic PLC
NYSE:MDT
124.8B USD 3.6 26.2 14.8 21.4
DE
Siemens Healthineers AG
XETRA:SHL
51.1B EUR 2.2 23.8 13.4 19
US
Becton Dickinson and Co
NYSE:BDX
56.8B USD 2.6 33.8 12.5 21.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.6B USD 13.1 53.1 38.2 42.3
US
Edwards Lifesciences Corp
NYSE:EW
48.9B USD 8.3 35.7 25.5 28
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.7B USD 1.9 17.5 13 15.7
US
Resmed Inc
NYSE:RMD
35.8B USD 6.8 24.9 17.8 19.8

See Also

Summary
BSX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BSX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BSX stock valuation using valuation multiples.
Wall Street Estimates
BSX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BSX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 307,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.